IL1B and colitis: The S. verbenaca-treated group showed a marked downregulation in the mRNA expression of Il-1β, Il-6, Il-12a and Il-23 (p < 0.05 vs. colitic control group), thus confirming the amelioration in the colonic inflammatory status exerted by the extract in this experimental model of colitis.